1. Home
  2. EYE vs GENB Comparison

EYE vs GENB Comparison

Compare EYE & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$17.61

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$16.23

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
EYE
GENB
Founded
1990
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
EYE
GENB
Price
$17.61
$16.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$31.22
$23.20
AVG Volume (30 Days)
2.4M
890.1K
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
202.78
N/A
EPS
0.38
N/A
Revenue
$1,987,488,000.00
N/A
Revenue This Year
$5.56
N/A
Revenue Next Year
$6.58
$16.58
P/E Ratio
$44.16
N/A
Revenue Growth
9.00
N/A
52 Week Low
$14.75
$11.00
52 Week High
$30.02
$16.75

Technical Indicators

Market Signals
Indicator
EYE
GENB
Relative Strength Index (RSI) 48.11 63.07
Support Level $14.84 $11.73
Resistance Level $29.56 $16.75
Average True Range (ATR) 1.00 1.17
MACD 0.26 0.34
Stochastic Oscillator 60.94 87.34

Price Performance

Historical Comparison
EYE
GENB

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: